MDGL — MADRIGAL PHARMACEUTICALS INC

Ownership history in Scientech Research LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Scientech Research LLC reported a position in MADRIGAL PHARMACEUTICALS INC (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.25% (2023 Q4)
Avg. % of fund
0.15%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 634 -1,302 -67.3% 0.10% $291K $458.66
2024 Q3 ADDED 1,936 +834 +75.7% 0.08% $411K $212.22
2023 Q4 INITIATED 1,102 — — 0.25% $255K —
% of Fund (quarterly)    MDGL price (monthly, adj. close)

Other funds also holding MDGL

As of 2025 Q4 — sorted by position size

PAULSON & CO. INC. 3Y 7Y 30.48% RTW INVESTMENTS, LP 3Y 7Y 11.63% Tao Capital Management LP 3Y 10.53% Avoro Capital Advisors LLC 3Y 7Y 10.35% BAKER BROS. ADVISORS LP 3Y 7Y 7.3% Tri Locum Partners LP 3Y 6.5% MPM BioImpact LLC 3Y 6.45% Nan Fung Group Holdings Ltd 3Y 6.19% Rock Springs Capital Management LP 3Y 7Y 4.17% Resolute Capital Asset Partners LLC 3Y 3.07%
← Back to Scientech Research LLC Holdings